Monday, January 7, 2008

Can Transamin be used in patients with DIC?

As a rule, the use of Transamin in patients with DIC is contraindicated. From a practical standpoint, however, it is not rare that secondary fibrinolysis occurs as an excessive response, which worsens bleeding or can even endanger patient’s life. To save patients from the life-threating situation caused by bleeding, there may be no choice but to use an antiplasminic agent.

In this case, Transamin is used until bleeding stops, and administration is discontinued as soon as possible after bleeding has stopped. This will minimize tissue damage in the kidney and other organs resulting from intravascular coagulation.

No comments: